Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 31;15(6):899.
doi: 10.3390/life15060899.

DuoStim Shows Comparable Efficacy but Better Efficiency than Two Conventional Stimulations in Poor/Suboptimal Responders Undergoing Vitrified Oocyte Accumulation for PGT-A

Stefano Canosa  1 , Alberto Revelli  1   2 , Danilo Cimadomo  3 , Alberto Vaiarelli  3 , Gianluca Gennarelli  1   4 , Daniela Guidetti  1 , Andrea Roberto Carosso  4 , Laura Rienzi  3   5 , Filippo Maria Ubaldi  3   6 , Francesca Bongioanni  1
Affiliations

DuoStim Shows Comparable Efficacy but Better Efficiency than Two Conventional Stimulations in Poor/Suboptimal Responders Undergoing Vitrified Oocyte Accumulation for PGT-A

Stefano Canosa et al. Life (Basel). .

Abstract

This study compared the DuoStim protocol with two conventional follicular phase stimulations for vitrified oocyte accumulation in poor-prognosis patients undergoing PGT-A. A retrospective analysis of 112 IVF cycles was conducted, with 66 cycles among patients undergoing DuoStim (DS-Group) and 46 among patients undergoing conventional follicular phase stimulations (DF-Group). The primary outcome was the time to live birth, while secondary outcomes included clinical pregnancy rate, miscarriage rate, live birth rate, and cumulative live birth rate. The final analysis included 66 patients in the DS-Group and 40 in the DF-Group, as 6 women (13%) in the DF-Group discontinued treatment after the first stimulation. Oocyte yield was similar between groups (8.4 ± 3.9 in DS-Group vs. 8.2 ± 4.0 in DF-Group, p = 0.80), as was the number of euploid blastocysts (0.9 ± 1.2 vs. 1.1 ± 1.1, p = 0.37). The cumulative live birth rate was 22.7% in the DS-Group and 25% in the DF-Group (multivariate odds ratio adjusted for maternal age and male factor: 1.05, p = 0.93). The time to live birth was significantly shorter in the DS-Group (81.5 ± 15.5 days) compared to the DF-Group (153.7 ± 78.2 days, p < 0.001). DuoStim showed similar efficacy but a shorter time to live birth.

Keywords: DuoStim; follicular phase stimulation; oocyte accumulation; oocyte vitrification; time to live birth.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Ovarian stimulation (OS) strategies for the treatment of poor/suboptimal responders undergoing PGT-A. Patients were suggested to undergo either two consecutive OS sessions in the same ovarian cycle (DS-Group) or two conventional OS sessions started in the follicular phase of two ovarian cycles (DF-Group). In the DS-Group, five days after the first oocyte retrieval, luteal phase stimulation was performed with an identical protocol (each square represents a day of the cycle). In the DF-Group, a variable time period after the first oocyte retrieval, a second conventional OS started in the follicular phase of a new but not always consecutive cycle was performed with an identical protocol (slanting lines represent the time period between the first oocyte retrieval and the start of the second OS). In both groups, oocyte vitrification was applied at the first OPU followed by their warming and insemination together with the fresh ones retrieved at the second OPU.
Figure 2
Figure 2
Timeline indicating the number of days needed (A) to obtain at least one euploid blastocyst, (B) to conclude the IVF cycle, and (C) to obtain an ongoing pregnancy (≥22 gestational weeks) in each of the two OS regimens. All times were significantly shorter using DuoStim.
See this image and copyright information in PMC

References

    1. Baerwald A.R., Adams G.P., Pierson R.A. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003;80:116–122. doi: 10.1016/S0015-0282(03)00544-2. - DOI - PubMed
    1. Baerwald A.R., Adams G.P., Pierson R.A. Characterization of ovarian follicular wave dynamics in women. Biol. Reprod. 2003;69:1023–1031. doi: 10.1095/biolreprod.103.017772. - DOI - PubMed
    1. Moffat R., Pirtea P., Gayet V., Wolf J.P., Chapron C., de Ziegler D. Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited. Reprod. Biomed. Online. 2014;29:659–661. doi: 10.1016/j.rbmo.2014.08.010. - DOI - PubMed
    1. Kuang Y., Chen Q., Hong Q., Lyu Q., Ai A., Fu Y., Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol) Reprod. Biomed. Online. 2014;29:684–691. doi: 10.1016/j.rbmo.2014.08.009. - DOI - PubMed
    1. Ubaldi F.M., Capalbo A., Vaiarelli A., Cimadomo D., Colamaria S., Alviggi C., Trabucco E., Venturella R., Vajta G., Rienzi L. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: New insight in ovarian reserve exploitation. Fertil Steril. 2016;105:1488–1495.e1. doi: 10.1016/j.fertnstert.2016.03.002. - DOI - PubMed

LinkOut - more resources